Mapping Cellular Plasticity in Tumor Progression and Drug Resistance
Join Dr. Itai Yanai as he provides an overview of how cellular plasticity is emerging as an important driving force underlying cancer progression and drug resistance.
Dr. Yanai will:
- examine the concept of cancer cell states present in a cancerous tumor prior to treatment, as well as those that accompany resistance to increasing drug doses.
- talk about his work published in his lab’s recent manuscript, “Cancer Cell States Recur Across Tumor Types and Form Specific Interactions with the Tumor Microenvironment,” and the recent developments in this project.
- discuss his lab’s work on drug-induced adaptation along a resistance continuum in cancer cells.
To view upcoming speakers or recordings of past presentations, visit the CBIIT Data Science Seminar Series webpage.
The Data Science Seminar Series presents talks from innovators in the cancer research and informatics communities both within and outside of NCI.
Dr. Yanai is a professor in the Department of Biochemistry and Molecular Pharmacology at New York University Grossman School of Medicine, and he is the scientific director of Applied Bioinformatics Laboratories. He has a Ph.D. from Boston University.
Upcoming Events
- Agentic AI in Cancer ResearchMay 27, 2025BTEC 2025 Annual Conference: The Epidemiology of Brain Metastases for Adult and Pediatric Brain TumorsMay 29, 2025Ctrl+Alt+Cure: Driving Smarter Cancer CareJune 11, 2025NCI Emerging Technologies Seminar: Programs and Resources to Support Technology Development for Cancer ResearchJune 17, 2025Data Jamboree: Enhancing Childhood Cancer Data Sharing and UtilitySeptember 29, 2025 - September 30, 2025NCI Office of Data Sharing’s Annual Data Sharing Symposium 2025: How Data Advances the Impact of Cancer ResearchSeptember 30, 2025 - October 01, 2025